Category Specific RSS

pharmaxis

FDA gives green light to Pharmaxis drug trial in liver cancer where there’s a desperate need for new treatments

Clinical stage drug development company, Pharmaxis (ASX: PXS) is making a name for themselves in the oncology sector, with their…

4 years ago

Dosing complete, Pharmaxis progresses with skin scarring trials led by Professor Fiona Wood

Our scars tell a story, whether it be grazed knees from the school yard or those mystery scrapes that make…

4 years ago

Pharmaxis streamlines operations with $2m sale of Australian distribution rights

Having successfully developed a number of drugs through to regulatory approval and commercial sales, Pharmaxis (ASX: PXS) is set to…

4 years ago